TELO Earnings Date: Dec 2, 2026 (Estimated) — Telomir Pharmaceuticals, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology
Updated
When is TELO's next earnings date?
Telomir Pharmaceuticals, Inc. Common Stock (TELO) is expected to report Q3 2026 earnings on Wednesday, December 2, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.03 on revenue of $500,000.
How did TELO do in its last earnings report?
In its most recent report on Aug 13, 2026 (Q2 2026), Telomir Pharmaceuticals, Inc. Common Stock posted EPS of -$0.79 versus the -$0.07 estimate, a miss of 1028.6%. Revenue was $0. The stock's 1-day post-earnings move was +3.8%.
How much does TELO stock move after earnings?
TELO beat EPS estimates in 3 of its last 5 reported quarters. Over the last 8 reports the stock moved an average of 5.7% (up or down) in the day after earnings.
About Telomir Pharmaceuticals, Inc. Common Stock
Telomir Pharmaceuticals, Inc. operates as a preclinical-stage pharmaceutical firm, concentrating its efforts on creating and launching novel therapeutic interventions. Its primary focus involves the development of TELOMIR-1, an innovative small molecule compound. This oral medication is being engineered to serve as a therapeutic solution against various age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, and also to assist in recovery post-chemotherapy. It achieves this by disrupting and inhibiting inflammatory pathways that are triggered by interleukin-17. Established in 2021, the company was initially known as Metallo Therapies Inc., officially adopting the name Telomir Pharmaceuticals, Inc. on October 10, 2022. The company's headquarters are located in Baltimore, Maryland.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | Q2 2026 | -0.07 | -0.79 | -1028.57% | $0 | ❌ Miss | +3.81% | +7.62% | +11.43% |
| 2026-05-14 | Q1 2026 | -0.07 | -0.03 | +57.14% | $0 | ✅ Beat | +3.25% | +6.50% | +2.44% |
| 2026-03-17 | Q4 2025 | -0.07 | -0.06 | +14.29% | $0 | ✅ Beat | -5.93% | -5.19% | -0.74% |
| 2025-11-10 | Q3 2025 | -0.07 | -0.03 | +57.14% | $0 | ✅ Beat | +3.65% | +2.19% | +2.92% |
| 2025-08-14 | Q2 2025 | -0.08 | -0.17 | -112.50% | $0 | ❌ Miss | -5.10% | -4.46% | -15.29% |
| 2025-02-04 | Q4 2024 | — | -0.08 | — | $0 | — | +3.22% | -3.00% | -8.10% |
| 2024-08-13 | Q2 2024 | — | -0.05 | — | $0 | — | -15.14% | +17.37% | +32.29% |
| 2024-05-13 | Q1 2024 | — | -0.23 | — | $0 | — | -5.33% | -9.31% | -17.27% |
Showing last 8 quarters.